SpecifEx-Hep B
Alternative Names: Hepatitis B virus-specific cytotoxic T lymphocytesLatest Information Update: 08 Aug 2007
At a glance
- Originator CellExSys
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 31 Jan 2007 Discontinued - Preclinical for Hepatitis B treatment in USA (Infusion)
- 10 Aug 2004 CellExSys has been acquired by Chromos Molecular Systems
- 09 Jul 2003 Preclinical trials in Hepatitis B treatment in USA (Infusion)